Key practical issues for antithrombotics in coronary interventions

Chairpersons: T. Cuisset, M. Valgimigli
Panellists: K. Al Faraidy, P. Urban

Learning Objectives

  • To review recent evidence on antithrombotics in coronary interventions
  • To discuss how to integrate scientific data into clinical decisions
  • To reflect on how to individualise treatment for each patient

Presentations available when logged in:

  • Session objectives
  • Timing for initiation of P2Y12 blockers in coronary interventions
  • Management of patients with oral anticoagulation undergoing PCI
  • DAPT duration after coronary interventions
  • What to expect from the new drugs entering the field of coronary interventions? (vorapaxar, cangrelor)
  • Session evaluation and key learnings